Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Casgevy (exa-cel)
Pharma
Vertex sets lofty $500M revenue goal for new products in '26
The company expects $500 million in 2026 from new products outside of its flagship CF franchise. Last year, the new drug total was $175.6 million.
Zoey Becker
Feb 13, 2026 12:02pm
As Vertex's pain launch gains more use, sales just missed in Q3
Nov 4, 2025 8:40am
UPDATED: Most expensive drugs in the US in 2025
Aug 11, 2025 3:00am
Vertex's proposed fertility support program shot down in court
Apr 1, 2025 11:48am
Vertex's Casgevy breaks ground with 1st commercial infusions
Nov 5, 2024 12:19pm
Vertex adds CDMO Lonza to Casgevy production network
Sep 24, 2024 9:41am
